Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.
1
Study Matches
AN OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY OF DAILY ORAL BCX7353 IN SUBJECTS WITH TYPE I AND II HEREDITARY ANGIOEDEMA
This is a clinical trial to determine the effectiveness of a daily oral medication in prevention of swelling attacks in patients with Hereditary Angioedema.
Type I or II HAE Used androgen therapy for prophylaxis of HAE episodes in past 12 months Greater than or equal 40 kg Access to appropriate rescue medication for HAE attacks
Exclusion Criteria:
Pregnant, breastfeeding, or planned pregnancy Prior enrollment in BCX 7353 study Known family history of sudden cardiac death